GFM
AGIO icon

GF Fund Management’s Agios Pharmaceuticals AGIO Stock Holding History

GF Fund Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$46.1K Sell
1,242
-68
-5% -$2.06K ﹤0.01% 396
2026
Q1 		$44.3K Buy
1,310
+165
+14% +$4.68K ﹤0.01% 415
2025
Q4 		$31.2K Sell
1,145
-105
-8% -$3.68K ﹤0.01% 454
2025
Q3 		$50.2K Sell
1,250
-210
-14% -$7.9K ﹤0.01% 393
2025
Q2 		$48.6K Hold
1,460
– – ﹤0.01% 417
2025
Q1 		$42.8K Buy
1,460
+263
+22% +$8.72K ﹤0.01% 436
2024
Q4 		$39.3K Buy
+1,197
New +$56.2K ﹤0.01% 416

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

GF Fund Management's AGIO Position: Q2 2026 in Review

GF Fund Management reduced its Agios Pharmaceuticals (AGIO) stake by 5.2% in Q2 2026, selling an estimated $2.06K and leaving 1,242 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #396.

GF Fund Management first reported a position in AGIO in Q4 2024 and has held it in 7 quarters since. The position peaked at $50.2K in Q3 2025. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • GF Fund Management held 1,242 shares of Agios Pharmaceuticals worth $46.1K as of Q2 2026.
  • GF Fund Management sold 68 Agios Pharmaceuticals shares in Q2 2026, an estimated $2.06K.
  • Agios Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #396 holding.
  • GF Fund Management first reported a position in Agios Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Agios Pharmaceuticals position peaked at $50.2K in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.